Daniel Bensen sold $2.1M of TYRA
Chief Operating Officer at Tyra Biosciences, Inc.. 131,411 shares at an average of $16.04, traded Nov 13, 2025, filed Nov 17, 2025.
Score components
- +20RoleCOO
- +25Trade size$2.1M at market
- +10Share of holdings soldSold 31% of holdings
- +8Cluster2 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +42.1%, 3m +76.0%, 6m +124.3%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-25-284935, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 13, 2025 | SOpen-market sale Common Stock10b5-1 | -1,111 | $16.00 | $18k | 426,870 | Nov 17, 2025 |
| Nov 14, 2025 | SOpen-market sale Common Stock10b5-1 | -110,228 | $16.02 | $1.8M | 316,642 | Nov 17, 2025 |
| Nov 17, 2025 | SOpen-market sale Common Stock10b5-1 | -18,572 | $16.11 | $299k | 298,070 | Nov 17, 2025 |
| Nov 17, 2025 | SOpen-market sale Common Stock10b5-1 | -1,500 | $17.07 | $26k | 296,570 | Nov 17, 2025 |
Related signals
Other insiders at Tyra Biosciences, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 31Weak | TYRAbuy Tyra Biosciences, Inc. | Rehan Verjee director | $20k 972 shares | - | |
| 28Weak | TYRAsell Tyra Biosciences, Inc. | Gilla Kaplan director | $529k 14,295 shares | -34% | |
| 8Weak | Tyra Biosciences, Inc. | Daniel Bensen Chief Discovery Officer | $263k 8,000 shares | -5% | |
| 8Weak | Tyra Biosciences, Inc. | Daniel Bensen Chief Discovery Officer | $228k 8,000 shares | -5% | |
| 16Weak | Tyra Biosciences, Inc. | Robert J More director | $250k 10,000 shares | -0% | |
| 15Weak | Tyra Biosciences, Inc. | Daniel Bensen Chief Discovery Officer | $181k 8,000 shares | -5% | |
| 28Weak | Tyra Biosciences, Inc. | Robert J More director | $5.0M 246,871 shares | -6% | |
| 43Moderate | Tyra Biosciences, Inc. | Daniel Bensen Chief Operating Officer | $2.0M 125,589 shares | -42% | |
| 35Weak | TYRAsell Tyra Biosciences, Inc. | Gilla Kaplan director | $94k 9,578 shares | -25% | |
| 53Moderate | TYRAsell Tyra Biosciences, Inc. | Gilla Kaplan director | $535k 51,814 shares | -58% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.